Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
06/2012
06/06/2012EP2460562A1 Cream-gel comprising at least one retinoid and benzoyl peroxide
06/06/2012EP2460561A1 Emulsion comprising at least one retinoid and benzoyl peroxide
06/06/2012EP2460539A1 Nanosphere or microsphere drug carrier, preparation method, composition and use thereof
06/06/2012EP2460537A1 Methods for treating conditions associated with MASP-2 dependent complement activation
06/06/2012EP2460532A1 Chemical method for sexual sterilisation and libido suppression in male mammals
06/06/2012EP2460525A1 Elastin stabilization of connective tissue
06/06/2012EP2460524A1 Medicinal composition for iontophoresis
06/06/2012EP2460523A1 Tablet
06/06/2012EP2460522A2 Methods and compositions using immunomodulatory compounds for treatment and management of cancers and other diseases
06/06/2012EP2460521A1 Methods of Using Sustained Release Aminopyridine Compositions
06/06/2012EP2460520A1 Methods for dosing an orally active 1,2,4-oxadiazole for nonsense mutation suppression therapy
06/06/2012EP2460519A1 Use of sigma ligands in bone cancer pain
06/06/2012EP2460518A1 Composition including a chondroprotective agent and vitamins
06/06/2012EP2460517A1 Reducing risk of type 2 diabetes (T2D)
06/06/2012EP2460515A1 Oral calcitonin compositions and applications thereof
06/06/2012EP2460514A1 Topical pharmaceutical gel compositions of flurbiprofen, glucosamine and chondroitin
06/06/2012EP2460513A1 A method for producing adapalene gels
06/06/2012EP2460509A1 Composition for the treatment of warts
06/06/2012EP2460415A1 Coated preparation
06/06/2012EP2460405A1 Antibacterial agent
06/06/2012EP2460010A1 Agonists and antagonists of human bitter taste receptor tas2r49 and uses thereof
06/06/2012EP2459717A1 Wd repeat 79 protein targeted therapy
06/06/2012EP2459716A1 Adenoviral-based vectors
06/06/2012EP2459589A1 Mutants pf4 polypeptides exhibiting an increased anti-angiogenic activity
06/06/2012EP2459581A2 Liver x receptor agonists
06/06/2012EP2459572A2 Spirocyclic amide derivatives
06/06/2012EP2459571A1 Nitroimidazooxazines and their uses in anti-tubercular therapy
06/06/2012EP2459570A1 Nitroimidazooxazine and nitroimidazooxazole analogues and their uses
06/06/2012EP2459568A1 Novel spiro compounds useful as inhibitors of stearoyl-coenzyme a delta-9 desaturase
06/06/2012EP2459567A2 Phthalocyanine derivative consisting of a mixture of 4 isomers
06/06/2012EP2459566A1 Tricyclic inhibitors of jak
06/06/2012EP2459564A2 Cyclopropyl modulators of p2y12 receptor
06/06/2012EP2459563A2 5-ht3 receptor modulators, methods of making, and use thereof
06/06/2012EP2459562A1 Pyrrolo [1, 2-b]pyridazine derivatives as janus kinase inhibitors
06/06/2012EP2459561A1 Poly (adp-ribose) polymerase (parp) inhibitors
06/06/2012EP2459560A1 Ring-annulated dihydropyrrolo[2,l-a]isoquinolines
06/06/2012EP2459559A1 Condensed pyridine derivatives useful as potent inhibitors of the protein kinase ck2
06/06/2012EP2459557A1 Cyclic (aza)indolizinecarboxamides, their preparation and their use as pharmaceuticals
06/06/2012EP2459556A1 2, 7 -naphthyridin- 1 -one derivatives as syk kinase inhibitors
06/06/2012EP2459555A1 Processes for crystallization of rivaroxaban
06/06/2012EP2459554A2 Substituted benzamide derivatives as glucokinase (gk) activators
06/06/2012EP2459553A1 Furazanobenzimidazoles as prodrugs to treat neoplastic or autoimmune diseases
06/06/2012EP2459551A1 Dihydrobenzoindazoles
06/06/2012EP2459550A2 R-7-(3-aminomethyl-4-methoxyimino-3-methyl-pyrrolidin-1-yl)-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-[1,8]naphthyridine-3-carboxylic acid and l-aspartic acid salt, process for the preparation thereof and pharmaceutical composition comprising the same for antimicrobial
06/06/2012EP2459549A1 Tetrahydroquinoxaline urea derivatives, preparation thereof, and therapeutic use thereof
06/06/2012EP2459548A1 Tetrahydroquinoxaline urea derivatives, preparation thereof, and therapeutic use thereof
06/06/2012EP2459546A1 New bicyclic dioxanes, their preparation and their use as fragrant compounds
06/06/2012EP2459544A2 Prodrugs of desazadesferrothiocin polyether analogues as metal chelation agents
06/06/2012EP2459543A1 Benzo [e][1, 3]oxazin-4-one derivatives as phosphoinositide 3-kinase inhibitors
06/06/2012EP2459542A1 Selective alpha 2b/2c agonists
06/06/2012EP2459541A1 Dihydropyrimidone amides as p2x7 modulators
06/06/2012EP2459540A2 Preparation of fipamezole
06/06/2012EP2459535A1 Pyridine and pyrazine derivatives as protein kinase modulators
06/06/2012EP2459533A1 Small molecule inhibitors of isoprenylcysteine carboxyl methyltransferase with potential anticancer activity
06/06/2012EP2459532A1 Antitumor 1,2-diphenylpyrrole compounds and their preparation process
06/06/2012EP2459531A2 Synthesis and use of vildagliptin for the preparation of pharmaceutical dosage forms
06/06/2012EP2459530A1 2-amino-2-phenyl-alkanol derivatives, preparation thereof, and pharmaceutical compositions containing same
06/06/2012EP2459529A1 Substituted phenoxypropylcycloamine derivatives as histamine-3 (h3) receptor ligands
06/06/2012EP2459524A2 Novel compounds as modulators of glucocorticoid receptors
06/06/2012EP2459520A1 Crystalline forms of fesoterodine fumarate and fesoterodine base
06/06/2012EP2459517A1 Polymorphic form of toremifene citrate and process for its preparation
06/06/2012EP2459510A1 Hydroxy fatty acid compounds and uses thereof for disease treatment and diagnosis
06/06/2012EP2459221A2 Pharmaceutical formulation
06/06/2012EP2459216A2 Immunogenic compositions including tlr activity modulators
06/06/2012EP2459215A1 Method and kit for treating nicotine addiction
06/06/2012EP2459211A1 Continuous subcutaneous administration of interferon- to hepatitis c infected patients
06/06/2012EP2459201A1 Hydrogel formulation comprising oxidative reductive potential water
06/06/2012EP2459200A1 Pharmaceutical compositions comprising modified fucans for use in the treatment of fibrous adhesions and other disorders
06/06/2012EP2459199A1 Fulvestrant in a dosage of 500mg for the treatment of advanced breast cancer
06/06/2012EP2459198A1 Use of 5h-dibenz / b, f/ azepine-5-carboxamide derivatives for treating fibromyalgia
06/06/2012EP2459197A1 Compounds for the reduction of -amyloid production
06/06/2012EP2459196A1 Plk inhibitor salts
06/06/2012EP2459195A1 Compositions and methods for inhibition of the jak pathway
06/06/2012EP2459194A1 Compositions and methods for treating parkinson's disease
06/06/2012EP2459193A1 Otamixaban for treatment of elderly and renal impaired non-st elevation myocardial infarction patients
06/06/2012EP2459192A1 Methods of treating neuropathic pain with benzimidazole derivative agonists of ppargamma
06/06/2012EP2459191A1 Mtor inhibitor and angiogenesis inhibitor combination therapy
06/06/2012EP2459190A1 Hexahydrocyclopentyl[¦]indazole 5-hydroxymethyl ethanols and derivatives thereof as selective glucocorticoid receptor modulators
06/06/2012EP2459189A1 Fatty acids as anti-inflammatory agents
06/06/2012EP2459188A1 Use of rosmarinic acid and the derivatives thereof to treat ciguatera
06/06/2012EP2459187A1 Compositions and methods for inhibiting hair growth
06/06/2012EP2459186A1 Ophthalmic solution for protecting internal structures of the eyeball against uv-a rays or for the treatment of keratoconus with a trans-epithelial cross-linking technique
06/06/2012EP2459185A1 Composition comprising alpha-lipoic acid and carnosine for treating the phantom limb syndrome
06/06/2012EP2459184A1 Modulation of sgk1 expression in th17 cells to modulate th17-mediated immune responses
06/06/2012EP2459183A1 Methods for treatment of pain
06/06/2012EP2459182A1 Injectable formulation for treatment and protection of patients having an inflammatory reaction or an ischemia-reperfusion event
06/06/2012EP2459181A2 Compositions for generating an antigen specific immune response
06/06/2012EP2459180A1 Multi-layered, multiple unit pharmaceutical compositions
06/06/2012EP2459176A2 Crystallization method and bioavailability
06/06/2012EP2459173A1 Pharmaceutical compositions for the treatment of cancer and other diseases or disorders
06/06/2012EP2459172A1 Combination of dapsone with adapalene
06/06/2012EP2459170A2 A stable composition of ready-to-use gemcitabine injection
06/06/2012EP2459169A1 Bladder instillation compositions for treating bladder cancer
06/06/2012EP2459162A2 Injectable composition combining a filling agent and a fibroblast growth medium
06/06/2012EP2459159A2 Aqueous barrier solution for protecting skin from non-water-soluble substances
06/06/2012EP2459149A2 Antibacterial combinations comprising a garlic extrtact or s-allyl cysteine
06/06/2012EP2459015A1 Microbially-stable vitamin e solutions
06/06/2012EP2459000A1 Flavanones-containing food compositions
06/06/2012EP2458999A1 Flavanones-containing food compositions
06/06/2012EP2458996A1 Novel oral forms of a phosphonic acid derivative
1 ... 1195 1196 1197 1198 1199 1200 1201 1202 1203 1204 1205 1206 1207 1208 1209 1210 1211 1212 1213 1214 1215 ... 7860